Physician profile
Christopher L Shultz
NPI 1316334089
$54,320.24
in general payments reported to CMS, 2019-2025
12 companies · $1,487 in 2025
The $1,487 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $31K · 2021: $16K · 2022: $952 · 2023: $1,649 · 2024: $2,927 · 2025: $1,487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,243 · Food and Beverage: $2,820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,243.33 |
| Food and Beverage | $2,820.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,000.00 | 2020 | |
| Smith+Nephew, INC. | $14,298.31 | 2020-2024 | Evos, Conquest Fn |
| Southtech Orthopedics | $11,339.68 | 2020-2021 | |
| Stryker Corporation | $4,067.12 | 2021-2025 | Iconix, Procinch, Salvation |
| Gemini Mountain Medical, LLC | $2,478.31 | 2022-2024 | |
| Alliance Medical | $1,180.53 | 2025 | |
| Miach Orthopaedics, INC. | $325.77 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $269.91 | 2022-2025 | Comprehensive Shoulder System, Aperfix Femoral Implant |
| Impactortho, INC. | $176.16 | 2024 | |
| Depuy Synthes Sales INC. | $124.29 | 2022 | |
| Vericel Corporation | $42.24 | 2023-2024 | Maci |
| Ferring Pharmaceuticals INC. | $17.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Shultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.